Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Tuesday, November 10, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
Authors
Posts by Ogkologos
Ogkologos
4396 POSTS
0 COMMENTS
Undetectable MRD and Extended PFS More Common with MRD-guided Ibrutinib-Venetoclax than...
Ogkologos
-
October 13, 2025
0
ESMO’s Special Consultative Status with United Nations Economic and Social Council...
Ogkologos
-
October 10, 2025
0
FDA Approves Imlunestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast...
Ogkologos
-
October 10, 2025
0
EMA Recommends Extension of Indications for Selumetinib
Ogkologos
-
October 9, 2025
0
ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical...
Ogkologos
-
October 8, 2025
0
Exploratory 4-year Analysis Continues to Support Adding 3 Years of Ribociclib...
Ogkologos
-
October 8, 2025
0
How you can do your part in the AI transformation of...
Ogkologos
-
October 7, 2025
0
Increased Risk of Haematologic Malignancies Among Children and Adolescents Exposed to...
Ogkologos
-
October 7, 2025
0
ESMO Welcomes New Cancer Focused UN Political Declaration on Non-Communicable Diseases
Ogkologos
-
October 6, 2025
0
EMA Recommends Extending Indications for Pembrolizumab and Adopted a New Pharmaceutical...
Ogkologos
-
October 3, 2025
0
1
...
36
37
38
...
440
Page 37 of 440
MOST POPULAR
Selpercatinib Approved for Thyroid and Lung Cancers with RET Gene Alterations
June 15, 2020
ΚΑΡΚΙΝΟΣ ΗΠΑΤΟΣ
December 10, 2018
Osteoblasts Are “Warrior” Bone Cells That Can Suppress Bone-Metastatic Breast Cancer...
June 10, 2019
The American Society of Clinical Oncology and the American Cancer Society:...
February 1, 2022
Load more
HOT NEWS
6 highlights from our Black in Cancer conference
Cancer Research UK releases 2022 gender and ethnicity pay gap reports
Pharmacokinetic and Pharmacodynamic Interactions Between Anticancer and Antiviral Drugs
The HPV Vaccine: Increasing the Use of an Important Cancer Prevention...
Ελληνικά
English (UK)